# Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia

> **NCT01350440** · PHASE2 · COMPLETED · sponsor: **University of South Florida** · enrollment: 5 (actual)

## Conditions studied

- Spinocerebellar Ataxia

## Interventions

- **BIOLOGICAL:** IVIG

## Key facts

- **NCT ID:** NCT01350440
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01350440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01350440, "Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01350440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*